C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Patents for C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
06/2007
06/12/2007	US7230005 Compounds and methods for lowering the abuse potential and extending the duration of action of a drug
05/2007
05/31/2007	CA2630703A1 Processes for reducing contaminating michael acceptor levels in oxycodone and other compositions
05/30/2007	EP1789047A2 Treatment of diseases using nalmefene and its analgos
05/24/2007	US20070117831 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
05/24/2007	US20070117830 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
05/24/2007	US20070117829 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
05/23/2007	EP1730151A4 Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
05/18/2007	WO2007055184A1 Therapeutic or prophylactic agent for functional bowel disorder
05/18/2007	CA2628971A1 Therapeutic or prophylactic agent for functional bowel disorder
05/16/2007	CN1964976A Extraction of alkaloids from opium
05/10/2007	US20070105884 Opiate analogs selective for the delta-opioid receptor
05/09/2007	CN1960994A Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
05/03/2007	WO2007022535A3 Prodrugs of active agents
05/03/2007	US20070099946 Synthesis of R-N-methylnaltrexone
04/2007
04/25/2007	EP1543010B1 N-substituted hydromorphones and the use thereof
04/19/2007	WO2007043518A1 Therapeutic agent for nausea and/or vomiting
04/19/2007	US20070088162 Oxidation of thebaine by hydroperoxide in the presence of oxalic acid mixed with acetic or formic acid; basification of the 14-hydroxycodeinone oxalate and catalytic hydrogenation to yield oxycodone transforming to the hydrochloride salt; by-product inhibition; reproduction; efficiency
04/19/2007	CA2625495A1 Therapeutic agent for nausea and/or vomiting
04/11/2007	EP0897726B1 Antipruritic agent
04/05/2007	WO2005103697A3 Immunoassays for buprenorphine and norbuprenorphine
04/04/2007	CN1939920A Eastern poppy base compound and its medical use
04/03/2007	US7199129 Derivatives of morphine-like opioid compounds
03/2007
03/29/2007	WO2007014137A3 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents
03/29/2007	US20070072889 Hydrocodone polymorphs
03/28/2007	CN1938028A Anti-itching agent
03/22/2007	WO2007031284A1 Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
03/22/2007	WO2006138020A3 A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
03/22/2007	CA2621817A1 Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
03/14/2007	EP1762569A1 Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
03/14/2007	EP1560833B1 Preparation of codeine from morphine
03/07/2007	EP1758908A1 Extraction of alkaloids from opium
03/07/2007	EP1758452A1 Synthesis of metabolically stable analgesics, pain medications and other agents
02/2007
02/28/2007	EP1756570A2 Immunoassays for buprenorphine and norbuprenorphine
02/22/2007	WO2007022535A2 Prodrugs of active agents
02/22/2007	WO2006099351A3 Hydrocodone polymorphs
02/21/2007	CN1918168A Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
02/15/2007	US20070037982 Preparation of oxycodone
02/14/2007	CN1914210A Method for the catalytic production of hydrocodone and hydromorphone
02/08/2007	WO2006127899A3 (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use
02/08/2007	WO2006127898A3 (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use
02/01/2007	CA2615774A1 Large substituent, non-phenolic opioids
01/2007
01/25/2007	WO2006098855A3 Processes for preparing morphinans and intermediates thereof
01/17/2007	EP1224188B1 Nasal delivery composition comprising the methane sulphonate salt of morphine and chitosan
01/16/2007	US7164021 Intensify therapy of analgesics; immunology diseases; antiinflammatory agents; drug abuse; diarrhea; cardiovascular disorders; antisecretory agents; respiratory system disorders
01/16/2007	US7163939 important in the progression of many disease states that are induced by the inappropriate proliferation of cells; anticancer agent
12/2006
12/28/2006	WO2006138020A2 A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
12/28/2006	CA2610859A1 A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
12/27/2006	EP1736157A1 Anti-itching agent
12/27/2006	CN1291717C Antipruritic
12/26/2006	US7153966 Preparing a mixture comprising oxycodone and a solvent, adjusting the pH of the mixture to less than 6 and heating the mixture at the temperature of at least 55 degrees C for a period of at least 1 hour; and subsequently; exposing the mixture to hydrogenation reagents
12/21/2006	WO2006135650A1 Method for separation and purification of naltrexone by preparative chromatography
12/21/2006	CA2611105A1 Method for separation and purification of naltrexone by preparative chromatography
12/20/2006	EP1732926A1 Mitotic kinesin inhibitors
12/13/2006	EP1730151A1 Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
12/13/2006	EP1658293B1 A method of preparation of oxycodone
12/13/2006	CN1876634A Sinomenine structure-modified compound and its preparation method
12/06/2006	EP1456212B1 6-aminomorphinane derivatives, method for the production and use thereof
11/2006
11/30/2006	WO2006127899A2 (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use
11/30/2006	WO2006127898A2 (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use
11/30/2006	WO2006126637A1 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
11/30/2006	WO2006126529A1 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
11/30/2006	CA2609662A1 (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use
11/30/2006	CA2609393A1 (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use
11/23/2006	US20060264452 Analgesics; immunomodulators and for treatment of drug dependence; for example, 5'-Bromo-17-(cyclopropylmethyl)-6,7-didehydro-3,14-dihydroxy-4,5 alpha -epoxypyrido[2',3':6,7]morphinan
11/23/2006	US20060263431 Opioid Sustained Release Formulation
11/08/2006	CN1860122A Method for the catalytic production of hydrocodone and hydromorphone
11/08/2006	CN1283317C Use of opioid kappa receptor-excited compound in preparing pharmaceuticals for treating septicemia
10/2006
10/31/2006	US7129248 Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
10/31/2006	CA2412554C 3-substituted morphines
10/26/2006	WO2006113696A1 Hydromorphone polymorphs
10/26/2006	CA2605919A1 Hydromorphone polymorphs
10/24/2006	US7125884 N-but-3-enyl norbuprenorphine and its use as analgesic
10/19/2006	WO2006109671A1 Crystals of morphinan derivative and process for producing the same
10/19/2006	US20060235039 Hydromorphone polymorphs
10/19/2006	CA2602968A1 Crystals of morphinan derivative and process for producing the same
10/18/2006	EP1711502A2 Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
10/11/2006	EP1709957A2 Sustained-release analgesic compounds
10/10/2006	US7119100 4,5-epoxy-6-methoxy-6,14-ethylene-7-(1-hydroxy-1-methyl-3-(thiophen-2-yl)-propyl)-17-(methyl, cyclopropyl methyl, cyclobutyl methyl or allyl) morphinan-3-ol; analgesics; opium addiction
10/05/2006	WO2006104656A1 Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof
10/05/2006	CA2602929A1 Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof
10/04/2006	EP1423392B1 Derivatives of morphine-like opioid compounds
10/03/2006	CA2256897C Morphinan derivatives and medical uses
10/03/2006	CA2213842C Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
09/2006
09/27/2006	EP1404341B1 Active substance combination for medicamentous therapy of nicotine dependency
09/21/2006	WO2006099351A2 Hydrocodone polymorphs
09/21/2006	WO2006098855A2 Processes for preparing morphinans and intermediates thereof
09/21/2006	CA2621943A1 Hydrocodone polymorphs
09/21/2006	CA2600687A1 Processes for preparing morphinans and intermediates thereof
09/19/2006	CA2249240C Indolomorphinan derivative and agent for curing and preventing cerebral disorder
09/14/2006	WO2006095836A1 Antipruritic agent for pruritus caused by multiple sclerosis
09/14/2006	CA2604071A1 Antipruritic agent for pruritus caused by multiple sclerosis
09/12/2006	US7105675 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence
08/2006
08/23/2006	CN1271072C Process for the preparation of 14-hydroxymorphine derivatives
08/17/2006	WO2006084412A1 Method for purifying noroxymorphone compounds
08/17/2006	WO2006084389A1 Method for purifying noroxymorphone compounds
08/17/2006	CA2597350A1 Process for purifying noroxymorphone compounds
08/16/2006	EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists
08/09/2006	EP1687310A1 Method for the catalytic production of hydrocodone and hydromorphone
08/08/2006	US7087619 Method for the treatment of urinary incontinence
08/03/2006	US20060173029 Oxycodone hydrochloride having less than 25 ppm 14- hydroxycodeinone

1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24